Home > Animal Health & Nutrition > Veterinary Services > Dog Dewormers Market

Dog Dewormers Market Share

Report ID: GMI11674
Published Date: Oct 2024
Report Format: PDF

Download Free Sample

Dog Dewormers Market Share

The market is characterized by its fragmented nature, with a diverse mix of large multinational corporations, and small and mid-sized companies all vying for market share. Key strategies for companies in this sector include the development and introduction of innovative deworming treatments that offer enhanced efficiency and cost-effectiveness. This focus on innovation drives competition and advances in the market, as companies seek to address evolving clinical needs and improve pet health outcomes. By leveraging novel formulations and delivery methods, businesses aim to capture a larger market share and meet the rising demand for advanced dog deworming solutions.

Dog Dewormers Market Companies

Some of the eminent market participants operating in the Dog Dewormers industry include:

Bayer AG
Beaphar
Bimeda, Inc.
Boehringer Ingelheim International GmbH
Ceva Santé Animale
Durvet Animal Health Products
Elanco Animal Health Incorporated
Jurox Pty Limited
Merck & Co., Inc.
Ourofino Animal Health
PetIQ, LLC.
Sava Healthcare Limited
Vetoquinol
Virbac SA
Zoetis Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The industry was valued at approximately USD 1.4 billion in 2023 and is projected to grow at a 9.5% CAGR from 2024 to 2032, driven by increased pet ownership and a rising focus on zoonotic diseases.

Tablets and chewable treats generated the highest revenue of USD 768.6 million in 2023. Their popularity stems from their convenience, ease of administration, and high compliance rates among pet owners.

In 2023, North America's market recorded USD 513.3 million in revenue and is anticipated to grow at a CAGR of 9.1% between 2024 and 2032. The high pet ownership rates in the U.S. and Canada drive this demand, as owners seek to keep their pets free from parasites.

Some of the prominent market participants include Bayer AG, Beaphar, Bimeda, Inc., Boehringer Ingelheim International GmbH, Ceva Sant